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Abstract 
Oromandibular dystonia consists of prolonged spasms of contraction of the muscles of the mouth and jaw. Pri-
mary idiopathic forms and secondary forms exist. Secondary dystonia develops due to environmental factors; 
some cases of cranial dystonia after dental procedure have been reported, but the causal relationship between 
these procedures and dystonia remains unclear. Traumatic situations in the mouth, such as poor aligned dentures 
or multiple teeth extractions may cause an impairment of proprioception of the oral cavity, leading to subsequent 
development of dystonia. The clinical characteristics of oromandibular dystonia are classified according to the 
affected muscles. The muscles involved may be the muscles of mastication, muscles of facial expression, or the 
muscles of the tongue. At present, there is no known cure for OMD. The mainstay of treatment for most focal 
dystonia is botulinum toxin injections. It is important for the dentist to be familiar with oromandibular dystonia, 
as it can develop after dental treatment and is often misdiagnosed as a dental problem.
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Introduction
Oromandibular dystonia consists of prolonged spasms 
of contraction of the muscles of the mouth and jaw (1). 
It clinically manifests as sustained involuntary muscle 
contraction with twisting or repetitive movement or ab-
normal postures and a wide variation in clinical pre-
sentation, depending on musculature affected, severity, 
and distribution (2). In cranial dystonia, oromandibular 
dystonia occurs together with blepharospasm, this as-
sociation is known as Meige’s syndrome or Brueghel’s 
syndrome (1).
The objective of this review is to carry out an update of 
this clinical entity, focusing on its dental implications.
Classification and etiology
Dystonia can be classified anatomically into regions of 
distribution such as focal, segmental, multifocal and 
generalized, and further into the affected body parts 
(2).
Another method for classifying dystonia is by etiology, 
into primary and secondary. Primary forms are also re-
ferred to as idiopathic, inherited or familial with genetic 
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predisposition (2, 3). Secondary dystonia develops due 
to environmental factors: peripheral traumatic or surgi-
cal incidents, diseases of the brain (neurodegenerative 
disorders, cerebral infarction), and after treatment with 
neuroleptics or other medications (drug-induced dysto-
nia) (4-6). The most common form of all secondary dys-
tonia is tardive dystonia, which develops as a side effect 
of long-term treatment with antipsychotic drugs (2).
Tan and Jankovic conducted a clinical comparison be-
tween tardive and idiopathic oromandibular dystonia, 
they concluded that oro-facial-lingual stereotypes were 
significantly more frequent in the tardive than the idio-
pathic group. Dystonia in tardive oromandibular dysto-
nia is more likely to be restricted to the oromandibular 
region, whereas in patients with idiopathic oromandibu-
lar dystonia, cervical dystonia often coexists (7). 
Some cases of cranial dystonia after dental procedures 
have been reported, although the causal relationship 
between these procedures and dystonia is still unclear. 
Sankhla et al. (8) reported 27 peripherally induced 
OMD, four of which were wearing new sets of dentures, 
including one patient with an ill fitting dental bridge. 
The patients with ill fitting dentures had a history of us-
ing their jaw muscles to manipulate their jaw position to 
adapt to the new dentures. These malaligned dentures 
may have caused a proprioception impairment of the 
oral cavity leading to subsequent development of dys-
tonia or so-called “edentulous dyskinesia”. Hamzei et 
al. (9) reported the case of a woman with long-standing 
multiple system atrophy with predominance of par-
kinsonism who developed facial dystonia within a few 
hours and severe life-threatening laryngeal dystonia 
with respiratory failure within 3 days after insertion of 
ill-fitting dentures.
Clinical Characteristics
The clinical characteristics of oromandibular dystonia 
are classified according to the affected muscles. The 
muscles involved may be the muscles of mastication, 
muscles of facial expression, or the muscles of the tongue 
10). Patients may present with jaw opening, jaw closing, 
jaw deflecting, jaw retruding dystonia, or a combina-
tion of any of these. The involuntary mandibular move-
ments may be repetitive or sustained. Dystonic spasms 
may result in nasal contractions, facial grimacing, lip 
pursing, lip sucking, chewing, bruxism, tongue dyski-
nesias, retractions of corners of mouth, and platysma 
contractions. Other associated symptoms may include 
chewing difficulties, dysarthria, dysphagia, dysphonia, 
or breathing difficulties (9, 11).
Patients often report triggers such us stress, talking, 
chewing and praying (12). Often patients report that 
they have learned certain “sensory tricks” that help re-
duce the dystonia such as sleeping, relaxing, talking, 
singing, lip biting, tongue posturing, swallowing, chew-
ing gum (12).
Diagnosis
The diagnosis of OMD is clinical and complicated, 
since it can present in various forms and with differ-
ent degrees of severity. The differential diagnosis with 
TMJ disorders (such as bruxism or spontaneous con-
dylar dislocation), hemifacial spasm and psychological 
disorders is necessary (10). Although this is an infre-
quent pathological entity, the dentist should be familiar 
with the symptomatology as it is often misdiagnosed as 
a “dental problem” and may cause considerable func-
tional and psychosocial disability (8).
Treatment
At present there is no etiologic treatment for OMD (10). 
Oral medication is the usual first line of treatment. There 
is no evidence-based information about the efficacy of 
the different pharmacologic therapeutic options cur-
rently being applied in dystonia (13). Medications are 
prescribed in early stages and may have some effects 
in controlling dystonic movements. Systemic pharma-
cologic therapy benefits about one third of patients and 
consists of a wide variety of medications (cholinergics, 
benzodiazepams, antiparkinsonism drugs, anticonvul-
sants, baclofen, carbamazepine and lithium) (14). Al-
though most oral medications have a low success rate, 
anticholinergic medications have been found to be the 
most effective oral medication for the treatment of dy-
stonia (15).
Muscle afferent block (MAB), by intramuscular injec-
tion of anaesthetic and alcohol, has been used for the 
treatment of OMD. Yoshida et al. (16) studied the fac-
tors influencing this kind of treatment and concluded 
that MAB although is highly effective for OMD, it has 
no effect in patients with dyskinetic symptoms, thus 
OMD and oral/orofacial dyskinesia may have a differ-
ent physiopathology.
The second line of treatment is botulinum toxin (BTX) 
injections, the mainstay of treatment for most focal dy-
stonia. Botulinum toxin type A (BTX-A) blocks the 
release of acetylcholine at the presynaptic junction, 
producing a transient weakening of the muscle activity 
without systemic effects (17). Numerous studies have 
confirmed a 90-95% response rate to BTX injections 
(18). Bakke et al. (17) and Moller et al. (3,19) reported a 
better effect of BTX injections when guided with elec-
tromyography (EMG), permitting individual treatment 
plans with longer intervals between BTX injections and 
lower doses than with conventional treatment for OMD. 
On the other hand, botulinum neurotoxins may be im-
munogenic, and some patients can develop secondary 
nonresponsiveness to BTX-A following multiple injec-
tions. Nevertheless, there have been only rare reports 
of patients with OMD treated with BTX-A becoming 
immuno-resistant.
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Operative therapies include peripheral and central ner-
vous system procedures and are generally a last resort 
for individuals suffering with certain types of dystonia 
(10). In some patients with peripherally induced OMD, 
arthroscopy and other TMJ surgeries have been per-
formed, although without obtaining satisfactory results, 
and in some cases the condition worsened (8). Yoshida 
(20) performed surgical resection of the bilateral coro-
noid processes for 2 patients with severe trismus due to 
jaw-closing dystonia, in whom treatment by botulinum 
toxin injection or muscle afferent block therapy had 
been ineffective. The jaw opening increased to 50 mm 
in both patients. 
Conclusion
It is important for the dentist to be familiar with oro-
mandibular dystonia, as it can develop after dental 
treatment, very often being misdiagnosed as a dental 
problem, and may cause considerable functional and 
psychosocial disability.
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